Drugs & TargetsFree Novartis drug combination Tafinlar + Mekinist receives EU approval for BRAF V600-positive advanced NSCLC April 07, 2017Vol.43 No.14
Drugs & TargetsFree FDA accepts for review the application of Ibrutinib for cGVHD after failure of systemic therapy April 07, 2017Vol.43 No.14
Drugs & TargetsFree Amgen seeks to expand XGEVA indications to multiple myeloma in the US, Europe April 07, 2017Vol.43 No.14
Drugs & TargetsFree ESSA Pharma receives $1.2 million grant payment from CPRIT April 07, 2017Vol.43 No.14
FreeIn Brief SU2C names researchers to $12 Million “Dream Team” on colorectal cancer April 07, 2017Vol.43 No.14
FreeIn Brief BMS gives SU2C to $7.5 million to fund immuno-oncology grants April 07, 2017Vol.43 No.14
FreeIn Brief Jennifer Pietenpol named chief scientific advisor for Susan G. Komen April 07, 2017Vol.43 No.14
